State of Men’s Health Act
Summary
HR7602, the State of Men's Health Act, is an early-stage bill that directs HHS to study men's health and establish an Office of Men's Health. No funding is authorized, and the bill has no direct market impact at this stage. Retail investors should monitor for future appropriations or regulatory actions, but no tickers are actionable now.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7602 is a study-and-office creation bill with no authorized funding.
- 2.The bill is in early legislative stage; no market-moving provisions.
- 3.No specific companies or sectors are directly impacted at this time.
Market Implications
The bill does not create direct revenue streams or regulatory burdens for any public company. Healthcare sector investors should note the bipartisan interest in men's health but expect no near-term market impact. If the bill advances and appropriations follow, companies in preventive screening, diagnostics, and men's health therapeutics could see tailwinds, but that is speculative and distant.
Full Analysis
The State of Men's Health Act (HR7602) was introduced on February 20, 2026, by Rep. Carter (D-LA) and referred to the House Committee on Energy and Commerce. The bill requires the Secretary of HHS to study and report on men's health outcomes and establish an Office of Men's Health within HHS. It is a policy and study bill, not a spending bill. No dollar amount is authorized or appropriated. The bill is in the earliest legislative stage with no committee hearings or markups. A companion bill (S5113) exists in the Senate, indicating bipartisan interest, but both are in committee. The legislative path requires committee action, House and Senate passage, and presidential signature. Given the procedural nature and lack of funding, there is no direct revenue impact on any publicly traded company. The bill's findings highlight health disparities but do not mandate specific spending or regulatory changes. Investors should watch for future appropriations or agency rulemaking, but currently no tickers are affected.
Key Legislators
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.0B Department of Health and Human Services Grant
DEPARTMENT OF SOCIAL SERVICES CONNECTICUT: $6.9B Department of Health and Human Services Grant
STATE OF COLORADO - DEPT OF HEALTH CARE POLICY & FINANCING: $9.2B Department of Health and Human Services Grant
LOUSIANA DEPARTMENT OF HEALTH: $16.7B Department of Health and Human Services Grant
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $13.9B Department of Health and Human Services Grant
OKLAHOMA HEALTH CARE AUTHORITY: $8.1B Department of Health and Human Services Grant
ILLINOIS DEPARTMENT OF HEALTHCARE & FAMILY SERVICES: $23.4B Department of Health and Human Services Grant
NEBRASKA DEPARTMENT OF HEALTH & HUMAN SERVICES: $3.9B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →